14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

ZYNE Predictions History

3 years ago
JS predicted that ZYNE for 2020-12-24 is going $3.41 (-0.29%)

3 years ago
VinnyClaffey predicted that ZYNE for 2020-12-24 is going $3.41 (-0.29%)

Rank:

3 years ago
JS predicted that ZYNE for 2020-12-09 is going $4.37 (3.80%)

3 years ago
sander7100 yo bro predicted that ZYNE for 2020-07-09 is going $3.15 (-8.43%)

3 years ago
JS predicted that ZYNE for 2020-07-09 is going $3.51 (2.03%)

3 years ago
JS predicted that ZYNE for 2020-07-02 is going $3.99 (14.00%)

3 years ago
iHustle84 predicted that ZYNE for 2020-07-02 is going

4 years ago
joe1234 predicted that ZYNE for 2019-06-20 is going $13.18 (-2.30%)

4 years ago
JS predicted that ZYNE for 2019-06-11 is going $11.75 (-12.96%)

4 years ago
joe1234 predicted that ZYNE for 2019-06-11 is going $11.93 (-11.63%)

Click to get the best stock tips daily for free!

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba P... ZYNE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT